Vitek Tracz is a risk-taker. He put his money into open-access publishing when free Internet journals seemed like a long shot. "Everybody promised me that open access would not succeed," recalls the scientific publisher. "They said I would go bankrupt. I thought there was a very high chance of that, myself. But it now turns out to be significantly profitable." Two years ago he sold his BioMed Central publicationsâ€”there are now about 200 of themâ€”to Berlin-based Springer for an undisclosed sum, thought to be in the region of $50-million.
Article Source: Chronicle of Higher Education